Product Name :
Alemtuzumab
Search keywords :
CD52
drugId :
null
Target Vo:
CAMPATH-1 antigen
Target Vo Short Name :
CD52
Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects
First Approval Country :
United States
First Approval Date Filter:
2001
Origin Company_Name :
Genzyme Corp
Active Company_Name :
Genzyme Corp
Active Indication_Name:
Leukemia, Lymphocytic, Chronic, B-Cell
In Active Indication_Name:
Sezary Syndrome
Termination Status :
China Termination Status :
Phase 2 Clinical
Highest Status:
Approved
China Highest Status:
Pending
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hsc70 Antibody
GLUT2 Antibody
Caspase-14 Antibody: Caspase-14 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 28 kDa, targeting to Caspase-14. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.